SELLAS Life Sciences Group, Inc. (SLS)

4.35 +0.37 (+9.30%) USD  |  NASDAQ  |  Jan 20, 15:43
More

SELLAS Life Sciences Group Long Term Deferred Assets (Quarterly)

Long Term Deferred Assets (Quarterly) Chart

View Long Term Deferred Assets (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Assets (Quarterly) Benchmarks

View Long Term Deferred Assets (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. --
Amicus Therapeutics, Inc. --
Geron Corp. --
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade